Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envoy MedicalCOCH +1.63%24 PB Ratio is 5.05 as of Jul. 22, 2026, which is 1% above its 10-year median of 4.98. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.12 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Envoy Medical ranks worse than 80.41% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-22), Envoy Medical's share price is $0.6921. Envoy Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $0.14. Hence, Envoy Medical's PB Ratio of today is 5.05.
The historical rank and industry rank for Envoy Medical's PB Ratio or its related term are showing as below:
COCH'
s PB Ratio Range Over the Past 10 Years
Min: 2.84 Med: 4.98 Max: 15.25
Current: 4.94
During the past 5 years, Envoy Medical's highest PB Ratio was 15.25. The lowest was 2.84. And the median was 4.98.
COCH's PB Ratio is ranked worse than 80.41% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs COCH: 4.94
During the past 3 years, the average Book Value Per Share Growth Rate was 39.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Envoy Medical was 39.60% per year. The lowest was 27.30% per year. And the median was 33.45% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Envoy Medical PB Ratio Related Terms
Envoy Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Envoy Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Envoy Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envoy Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Envoy Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Envoy Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Envoy Medical (COCH) has a PB Ratio of 5.05 as of Jul. 22, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Envoy Medical and its competitors. This is near median its historical median of 4.98. Over the past decade, Envoy Medical's PB Ratio has ranged from 2.84 to 15.25. According to the industry distribution chart, Envoy Medical ranks #632 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 80.4%.
Is Envoy Medical's PB Ratio too high?
Envoy Medical's current PB Ratio of 5.05 is near median its 10-year median of 4.98. Over the past 10 years, this metric has ranged from a low of 2.84 to a high of 15.25. The Medical Devices & Instruments industry median PB Ratio is 2.05. Envoy Medical's value of 5.05 is 146.3% above this industry median. Based on the distribution chart, Envoy Medical ranks #632 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's PB Ratio compare to SRTS and QTI?
According to the Medical Devices & Instruments industry distribution chart, Envoy Medical ranks #632 out of 786 companies for PB Ratio. This places Envoy Medical in the lower half of its industry. The industry median PB Ratio is 2.05. Envoy Medical's value of 5.05 is 146.3% above this benchmark. Historically, Envoy Medical's own PB Ratio has ranged from 2.84 to 15.25 over the past decade. While the company's 10-year median is 4.98 vs. the industry median of 2.05, Envoy Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envoy Medical's current PB Ratio of 5.05 is 146.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Envoy Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envoy Medical's current PB Ratio is 5.05, which is near median its own 10-year median of 4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.12, compared to a current price of $0.69 — trading 38.2% below its estimated fair value. The current PB Ratio is 5.05, which is near median its 10-year median of 4.98 and 146.3% above the Medical Devices & Instruments industry median of 2.05. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Envoy Medical (COCH), the current PB Ratio is 5.05 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envoy Medical (COCH) Overvalued in 2026?
Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued.
The current stock price of $0.69 is trading 38.2% below its estimated GF Value™ of $1.12.
GuruFocus considers Envoy Medical to be Possible Value Trap.
Key valuation signals for COCH:
PB Ratio: 5.05 (near median its 10-year median of 4.98)
GF Value™: $1.12 vs. price of $0.69 (38.2% below fair value)
Industry Position: 146.3% above the Medical Devices & Instruments median (#632 of 786)
No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score
Get the complete analysis for COCH
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COCH has been successfully added to your 
